Expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anemia patients
Friday, December 12, 2025 NIH clinical trial shows promise for people with treatment-limited, life-threatening disorder. A clinical trial…
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Although poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first-line maintenance for advanced ovarian cancer (OC),…
World’s largest-ever clinical trial launched to test treatments for Parkinson’s disease
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched,…
Two-dose therapy for S. aureus bloodstream infections on par with standard treatment
Wednesday, August 13, 2025 NIH-supported trial finds dalbavancin safe, effective for treating bacteremia Colorized scanning electron micrograph of…
Early clinical trial supports MASL as a targeted oral cancer treatment
Rowan University and Sentrimed®, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced…